Go to the profile of els@cancerprobe.com.au


Director, CancerProbe

About els@cancerprobe.com.au

A cancer therapeutics and diagnostic company.

CancerProbe has developed a novel approach for the identification of immune biomarkers and tumour antigens in solid cancers. CancerProbe's proprietary technology also reveals baseline immune responses that may identify the likelihood of benefit or toxicities from cancer therapies in specific patients or patient cohorts.

Contact els@cancerprobe.com.au